NCT03217149

Heliox for Neonate With Acute Respiratory Distress Syndrome (ARDS)

Heliox for Neonate With Acute Respiratory Distress Syndrome (ARDS): A Randomized Controlled Trial

• Status: Unknown
• Phase: N/A
• Study type: Interventional
• Enrollment: 200 (estimated)
• Sponsor: Daping Hospital and the Research Institute of Surgery of the Third Military Medical University · Academic / Other
• Sex: All
• Age: 30 Minutes – 28 Days
• Healthy volunteers: Not accepted

Summary

Acute respiratory distress syndrome (ARDS) in neonates has been defined, the role of heliox is not clear.This study aimed to determine whether ARDS neonate would benefit from heliox when oxygenation deteriorated on mechanical ventilation and to identify any potential risk factors related to mortality.

Detailed description

Acute respiratory distress syndrome (ARDS) can result in severe hypoxemia refractory to mechanical ventilation, mechanical ventilation including high frequency oscillation ventilation is the main method. But it is partial unuseful.

Conditions

• ARDS

Interventions

Type	Name	Description
DRUG	heliox combined with MV	heliox combined with MV is given to infant with ARDS
DRUG	MV	MV is given to infant with ARDS

Timeline

• Start date: 2017-09-01
• Primary completion: 2020-08-30
• Completion: 2020-08-30
• First posted: 2017-07-13
• Last updated: 2017-07-13

Locations

1 site across 1 country: China